Tumors from patients with humoral hypercalcemia of cancer produce a parathyroid hormone-related protein (PTHRP). We have developed two region-specific immunoassays capable of measuring PTHRP in plasma: an immunoradiometric assay directed toward PTHRP amino acid sequence 1 to 74 and a radioimmunoassay directed toward PTHRP amino acid sequence 109 to 138. Sixty normal subjects had low or undetectable plasma PTHRP (1 to 74) concentrations (mean, 1.9 pmol per liter) and undetectable PTHRP (109 to 138) concentrations (less than 2.0 pmol per liter). Patients with humoral hypercalcemia of cancer (n = 30) had elevated levels of both PTHRP (1 to 74) (mean, 20.9 pmol per liter) and PTHRP (109 to 138) (mean, 23.9 pmol per liter). The plasma concentrations of immunoreactive PTHRP correlated with the levels of urinary cyclic AMP excreted; in some patients, the concentrations decreased after the tumors were resected. Patients with chronic renal failure (n = 15) had plasma PTHRP (1 to 74) concentrations similar to those in the normal subjects, but their plasma PTHRP (109 to 138) concentrations were elevated (mean, 29.6 pmol per liter). The levels of both peptides were normal in patients with hyperparathyroidism and those with hypercalcemia due to various other causes. Breast milk contained high concentrations of PTHRP. An anti-PTHRP (1 to 36) immunoaffinity column failed to extract PTHRP (109 to 138) immunoactivity from plasma, suggesting that the C-terminal region circulates as a separate peptide. We conclude that plasma PTHRP concentrations are high in the majority of patients with cancer-associated hypercalcemia and that the circulating forms of PTHRP in such patients include both a large N-terminal (1 to 74) peptide and a C-terminal (109 to 138) peptide. Measuring the concentrations of PTHRPs may be useful in the differential diagnosis of hypercalcemia.
Source Information
Department of Medicine, West Haven Veterans Affairs Medical Center, Conn 06516.
This article has been cited by other articles:
Gilmore, J. L., Gonterman, R. M., Menon, K., Lorch, G., Riese, D. J. II, Robling, A., Foley, J.
(2009). Reconstitution of Amphiregulin-Epidermal Growth Factor Receptor Signaling in Lung Squamous Cell Carcinomas Activates PTHrP Gene Expression and Contributes to Cancer-Mediated Diseases of the Bone. Mol Cancer Res
7: 1714-1728
[Abstract][Full Text]
Jacobs, T. P., Bilezikian, J. P.
(2005). Rare Causes of Hypercalcemia. J. Clin. Endocrinol. Metab.
90: 6316-6322
[Abstract][Full Text]
Clines, G A, Guise, T A
(2005). Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer
12: 549-583
[Abstract][Full Text]
Normanno, N, De Luca, A, Aldinucci, D, Maiello, M R, Mancino, M, D'Antonio, A, De Filippi, R, Pinto, A
(2005). Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis. Endocr Relat Cancer
12: 471-482
[Abstract][Full Text]
Nakagawa, K., Sasaki, Y., Kato, S., Kubodera, N., Okano, T.
(2005). 22-Oxa-1{alpha},25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis
26: 1044-1054
[Abstract][Full Text]
Erdozain, J G, Egurbide, M V, Ruiz-Irastorza, G, Ojanguren, J, Aguirre, C
(2004). Systemic lupus erythematosus presenting as acute symptomatic hypercalcemia. Lupus
13: 132-134
[Abstract]
Horwitz, M. J., Tedesco, M. B., Sereika, S. M., Hollis, B. W., Garcia-Ocana, A., Stewart, A. F.
(2003). Direct Comparison of Sustained Infusion of Human Parathyroid Hormone-Related Protein-(1-36) [hPTHrP-(1-36)] Versus hPTH-(1-34) on Serum Calcium, Plasma 1,25-Dihydroxyvitamin D Concentrations, and Fractional Calcium Excretion in Healthy Human Volunteers. J. Clin. Endocrinol. Metab.
88: 1603-1609
[Abstract][Full Text]
Qian, J., Colbert, M. C., Witte, D., Kuan, C.-Y., Gruenstein, E., Osinska, H., Lanske, B., Kronenberg, H. M., Clemens, T. L.
(2003). Midgestational Lethality in Mice Lacking the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Is Associated with Abrupt Cardiomyocyte Death. Endocrinology
144: 1053-1061
[Abstract][Full Text]
Clemens, T. L., Qian, J., Colbert, M. C.
(2001). Editorial: Prenatal Lethality in PTH Type I Receptor Null Mice--Interrogating the Usual Suspects. Endocrinology
142: 5056-5058
[Full Text]
de Miguel, F., Fiaschi-Taesch, N., Lopez-Talavera, J. C., Takane, K. K., Massfelder, T., Helwig, J.-J., Stewart, A. F.
(2001). The C-Terminal Region of PTHrP, in Addition to the Nuclear Localization Signal, Is Essential for the Intracrine Stimulation of Proliferation in Vascular Smooth Muscle Cells. Endocrinology
142: 4096-4105
[Abstract][Full Text]
Carpio, L., Gladu, J., Goltzman, D., Rabbani, S. A.
(2001). Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways. Am. J. Physiol. Endocrinol. Metab.
281: E489-E499
[Abstract][Full Text]
Roodman, G. D.
(2001). Biology of Osteoclast Activation in Cancer. JCO
19: 3562-3571
[Abstract][Full Text]
Syed, M. A., Horwitz, M. J., Tedesco, M. B., Garcia-Ocaña, A., Wisniewski, S. R., Stewart, A. F.
(2001). Parathyroid Hormone-Related Protein-(1-36) Stimulates Renal Tubular Calcium Reabsorption in Normal Human Volunteers: Implications for the Pathogenesis of Humoral Hypercalcemia of Malignancy. J. Clin. Endocrinol. Metab.
86: 1525-1531
[Abstract][Full Text]
Falzon, M., Du, P.
(2000). Enhanced Growth of MCF-7 Breast Cancer Cells Overexpressing Parathyroid Hormone-Related Peptide. Endocrinology
141: 1882-1892
[Abstract][Full Text]
Dumon, J.-C., Jensen, T., Lueddecke, B., Spring, J., Barle, J., Body, J.-J.
(2000). Technical and Clinical Validation of an Immunoradiometric Assay for Circulating Parathyroid Hormone-related Protein. Clin. Chem.
46: 416-418
[Full Text]
Maeda, S., Sutliff, R. L., Qian, J., Lorenz, J. N., Wang, J., Tang, H., Nakayama, T., Weber, C., Witte, D., Strauch, A. R., Paul, R. J., Fagin, J. A., Clemens, T. L.
(1999). Targeted Overexpression of Parathyroid Hormone-Related Protein (PTHrP) to Vascular Smooth Muscle in Transgenic Mice Lowers Blood Pressure and Alters Vascular Contractility. Endocrinology
140: 1815-1825
[Abstract][Full Text]
GARCÍA-OCAÑA, A., GALBRAITH, S. C., VAN WHY, S. K., YANG, K., GOLOVYAN, L., DANN, P., ZAGER, R. A., STEWART, A. F., SIEGEL, N. J., ORLOFF, J. J.
(1999). Expression and Role of Parathyroid Hormone-Related Protein in Human Renal Proximal Tubule Cells during Recovery from ATP Depletion. J. Am. Soc. Nephrol.
10: 238-244
[Abstract][Full Text]
Iguchi, H., Miyagi, C., Tomita, K., Kawauchi, S., Nozuka, Y., Tsuneyoshi, M., Wakasugi, H.
(1998). Hypercalcemia Caused by Ectopic Production of Parathyroid Hormone in a Patient with Papillary Adenocarcinoma of the Thyroid Gland. J. Clin. Endocrinol. Metab.
83: 2653-2657
[Abstract][Full Text]
Falzon, M., Zong, J.
(1998). The Noncalcemic Vitamin D Analogs EB1089 and 22-Oxacalcitriol Suppress Serum-Induced Parathyroid Hormone-Related Peptide Gene Expression in a Lung Cancer Cell Line. Endocrinology
139: 1046-1053
[Abstract][Full Text]
Guise, T. A., Mundy, G. R.
(1998). Cancer and Bone. Endocr. Rev.
19: 18-54
[Abstract][Full Text]
Massfelder, T., Dann, P., Wu, T. L., Vasavada, R., Helwig, J.-J., Stewart, A. F.
(1997). Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: A critical role for nuclear targeting. Proc. Natl. Acad. Sci. USA
94: 13630-13635
[Abstract][Full Text]
Mawer, E. B., Walls, J., Howell, A., Davies, M., Ratcliffe, W. A., Bundred, N. J.
(1997). Serum 1,25-Dihydroxyvitamin D May Be Related Inversely to Disease Activity in Breast Cancer Patients with Bone Metastases. J. Clin. Endocrinol. Metab.
82: 118-122
[Abstract][Full Text]
Holt, E. H., Broadus, A. E., Brines, M. L.
(1996). Parathyroid Hormone-related Peptide Is Produced by Cultured Cerebellar Granule Cells in Response to L-type Voltage-sensitive Ca2+ Channel Flux via a Ca2+/Calmodulin-dependent Kinase Pathway. J. Biol. Chem.
271: 28105-28111
[Abstract][Full Text]
Wu, T. L., Vasavada, R. C., Yang, K., Massfelder, T., Ganz, M., Abbas, S. K., Care, A. D., Stewart, A. F.
(1996). Structural and Physiologic Characterization of the Mid-region Secretory Species of Parathyroid Hormone-related Protein. J. Biol. Chem.
271: 24371-24381
[Abstract][Full Text]
Vasavada, R. C., Cavaliere, C., D'Ercole, A. J., Dann, P., Burtis, W. J., Madlener, A. L., Zawalich, K., Zawalich, W., Philbrick, W., Stewart, A. F.
(1996). Overexpression of Parathyroid Hormone-related Protein in the Pancreatic Islets of Transgenic Mice Causes Islet Hyperplasia, Hyperinsulinemia, and Hypoglycemia. J. Biol. Chem.
271: 1200-1208
[Abstract][Full Text]
Plawner, L. L., Philbrick, W. M., Burtis, W. J., Broadus, A. E., Stewart, A. F.
(1995). Cell Type-specific Secretion of Parathyroid Hormone-related Protein via the Regulated versus the Constitutive Secretory Pathway. J. Biol. Chem.
270: 14078-14084
[Abstract][Full Text]
Wysolmerski, J., McCaughern-Carucci, J., Daifotis, A., Broadus, A., Philbrick, W.
(1995). Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development
121: 3539-3547
[Abstract]
Gucalp, R., Theriault, R., Gill, I., Madajewicz, S., Chapman, R., Navari, R., Ahmann, F., Zelenakas, K., Heffernan, M., Knight, R. D.
(1994). Treatment of Cancer-Associated Hypercalcemia: Double-blind Comparison of Rapid and Slow Intravenous Infusion Regimens of Pamidronate Disodium and Saline Alone. Arch Intern Med
154: 1935-1944
[Abstract]
Elias, A. N., Pandian, M. R., Jacowatz, J.
(1992). Parathyroid Hormone-Related Protein in Patients With Malignant Melanoma. Arch Dermatol
128: 278-279
[Abstract]
Previous
